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Abstract - This paper presents a microfluidic device for 
magnetophoretic separation red blood cells from blood under 
continuous flow. The separation method consist of continuous 
flow of a blood sample (diluted in PBS) through a microfluidic 
channel which presents on the bottom “dots” of ferromagnetic 
layer. By applying a magnetic field perpendicular on the 
flowing direction, the ferromagnetic “dots” generate a gradient 
of magnetic field which amplifies the magnetic force. As a 
result, the red blood cells are captured on the bottom of the 
microfluidic channel while the rest of the blood is collected at 
the outlet. Experimental results show that an average of 95 % 
of red blood cells is trapped in the device. 
  
I.  INTRODUCTION 
Separation of red blood cells (RBCs) from whole blood is 
often an essential step before the application of many clinical 
and molecular diagnostic tests on blood samples. The 
procedure is also useful in blood transfusion applications as 
it allows the selective transfusion of particular cell types. 
Separation can be possible due to hemoglobin. Hemoglobin 
is a conjugated metal-protein comprising of four polypeptide 
globins chains containing a ring structure covalently bonded 
with a central ferrous iron atom (Fe2+), which binds 
reversibly with oxygen. If is deoxygenated, each of the four 
iron atoms contains four unpaired electrons, giving the 
protein and the cell a substantial paramagnetic moment. 
White blood cells (WBCs) do not contain hemoglobin and 
are diamagnetic particles. These properties are the starting 
point for the trapping of RBCs particles using high gradient 
magnetic separation. 
Here, we report a simple microfluidic device for extraction 
of RBCs from blood under continuous flow. The device 
consists of a microfluidic channel with ferromagnetic “dots” 
deposited on its bottom. The geometry of the ferromagnetic 
layer and the application of an external magnetic field 
perpendicular to the flow direction generate a magnetic force 
on the RBCs present in the blood. The device offers other 
advantages, such as the collection of the RBCs inside the 
channel. The glass structure allows the complete visibility 
and analysis of the sample.  
 
   II. DEVICE DESIGN 
The structure of the device is presented in Fig. 1. A glass 
die with inlet / outlet holes and a 60µm-depth microfluidic 
channel is bonded to another glass die, on which a 
ferromagnetic structure – square “dots” (2x2x2µm) of Ni – 
was patterned. A permanent magnet generates an external 
magnetic flux of 0.2 T perpendicular on the flow direction. 
The blood is diluted with PBS and is flown through the 
microfluidic channel. The ferromagnetic “dots” generate a 
gradient of magnetic field which amplifies the magnetic 
force that acts on RBCs. As a result the RBCs are trapped by 
the ferromagnetic layer while the WBCs are flushed out with 
the plasma and the other blood components. 
 
Figure 1: Schematic view of the microfluidic device for RBCs trapping 
 
III.  ANALYTICAL CONSIDERATIONS 
If a uniform external magnetic field is applied normal to 
the axis of a ferromagnetic wire, it is deformed near the 
ferromagnetic wire, and generates a high gradient magnetic 
field, experienced by the magnetic particles moving around 
the wire. Therefore, blood cells flowing near the 
ferromagnetic wire experience a magnetic force created by 
the high gradient magnetic field near the ferromagnetic wire. 
The magnetic force of a rectangular wire on blood cells, 
located around the x-axis in Figure, can be calculated as 
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where ∆χ is the relative magnetic susceptibility of a blood 
cell relative to the buffer solution; µw and µB are the 
permeabilities of the ferromagnetic layer and the buffer 
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solution, respectively; VBC is the volume of the blood cell; a 
is the lateral dimension of the ferromagnetic structure; r and 
φ are the cylindrical coordinates of the distance and angle; H0 
is the external magnetic field; and ar and aφ are unit vectors 
for the distance and angle in the cylindrical coordinates. 
If the ferromagnetic structure is magnetically saturated, 
the first term of the magnetic force in the equation is 
independent of the external magnetic field, H0, and 
proportional to the square of the saturation magnetization 
field. The second and third terms of the magnetic force are 
linearly proportional to the saturation magnetization field and 
the external magnetic field.  
For magnetic particles placed on the x-axis (φ ≈ 0), sin2φ 
≈ 0, cos2φ ≈ 1, the ferromagnetic material attracts 
paramagnetic particles (RBCs) and repels diamagnetic 
particles (WBCs). For magnetic particles placed on the y-axis 
(φ ≈ 90), sin2φ ≈ 0, cos2 φ ≈ -1, the material attracts 
diamagnetic particles (WBCs) and repels paramagnetic 
particles (RBCs). The first geometric configuration has been 
called the paramagnetic capture (PMC) mode; the latter has 
been called the diamagnetic capture (DMC) mode. To 
summarize, the main parameters that influence the magnetic 
force applied on the particles affected by and external 
magnetic field are: the intensity and orientation of the 
magnetic field H0; the permeability of the buffer solution and 
the ferromagnetic material; the susceptibilities of the cells 
and the buffer solution and the dimension of the device. 
 
  IV. FABRICATION PROCESS 
The fabrication process of the device consists of three 
important steps: fabrication of the top wafer with the 
inlet/outlet holes and the microfluidic channel, fabrication of 
the bottom wafer with ferromagnetic concentrators and 
assembling of the wafers. 
The fabrication of the top wafer is presented in Figure 2. 
A 4” glass wafer Corning 7740 was used. A Cr/Au/ 
photoresist masking layer (Figure 2a) was used for 
fabrication of the microfluidic channel. A wet etching process 
in HF/HCl was used for 60µm deep-etching in glass (Figure 
2b). During the wet etching process the backside of the wafer 
was protected by a dummy silicon wafer bonded with wax on 
the glass wafer. The debonding of the wafer was performed 
on a hot plate. After removing of the Cr/Au/photoresist mask 
(Figure 2c) using classical resist stripper (NMP) – for 
photoresist and residual wax and Au and Cr etchants, a 
second Cr/Au/photoresist mask was applied on the other 
surface of the glass wafer (Figure 2d). Similar, a second wax 
bonding process will assure the protection of the microfluidic 
channel, while the wax served also as etch-stop layer for the 
deep wet etching process in HF/HCl (Figure 2e). Finally, the 
glass wafer was debonded from the dummy silicon wafer and 
the masking layer was removed with a similar procedure as 
was described before. 
The fabrication of the bottom wafer consists of a simple 
lift off process presented in Figure 3. On a 4” glass wafer 
(Corning 7740) a 5µm-thick photoresist mask (AZ4620 from 
Clariant) was deposited (Figure 3a). The metal layer Ti/Ni 
(50nm/2µm) was deposited in a CHA e-beam evaporator – 
(Figure 3b). The photoresist masking layer was finally 
removed in an ultrasonic bath using acetone. 
 
Figure 2: Main steps of the fabrication process of the top wafer: a) processing 
of the Cr/Au/ photoresist masking layer, b) wet etching of the microfluidic 
channel, c) removing of the masking layer, d) processing of the 
Cr/Au/photoresist masking layer for inlet/outlet holes, e) wet etching of 
inlet/outlet holes, f) removing of the second masking layer. 
 
Figure 3: Main steps of the bottom wafer fabrication process: a) deposition of 
the photoresist mask, b) deposition of Ti/Ni layer, c) removing of the 
photoresist mask. 
For the assembling of the glass wafers a simple adhesive 
bonding, using SU8-5, photoresist process was used. The 
technique consists of imprinting of an SU8-5 layer initially 
spun on a dummy silicon wafer (Figure 4a) on a Teflon 
cylinder (Figure 4b) and transferring further the adhesive 
from the cylinder to the top glass wafer (Figure 4c). This 
contact imprinting technique allowed deposition of a thin 
adhesive layer only on the bonding regions. In the last step, 
the wafers are manually align and bonded at 150OC for 30 
minutes with an applied pressure of 1000N (Figure 4d). 
Finally, the wafer is diced. An image of the fabricated device 
is presented in Figure 5. The dimensions of the chip are 
32mm x 9mm. 
 
Figure 4: Assembling of the wafers:  a) deposition of SU8 on a dummy wafer, 
b) imprinting of the SU8 on a Teflon cylinder, c) imprinting SU8 on the 
bonding area, d) alignment and bonding. 
 
Figure 5. Photo of  the microfluidic chip for RBCs trapping 
 
  V. TESTING 
Diluted blood (1:20 in PBS) was used for testing purpose. 
The permanent magnet creates an external magnetic flux of 
0.2 T and the flow rate was set in the range between 0.5 and 
0.7 ml/h (using a syringe pump). Two connectors fabricated 
by polymer printing secured the inlet and outlet connections.  
The results are based on the analysis of the quantity of red 
cells collected at the output of the device. Experimental 
results show an average of 5% of red blood cells collected at 
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the output of the device. Figure 6 presents the image with the 
field densities of cells before and after flowing the sample 
through the microfluidic device. 
 
Figure 6. Image of the field density of the cells on Neubauer 
hemocytometer before and after flowing the blood sample through the 
microfluidic device 
 
  V. CONCLUSIONS 
The paper presents a microfluidic device for 
magnetophoretic trapping of red blood cells under continuous 
flow, using high gradient of magnetic field. Experimental 
results show a good trapping efficiency that can be further 
improved. 
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